The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
Seva Sankalp Abhiyan 2026 is a nation-wide campaign on public service and outreach which is…
The 78th edition of Primetime Emmy Awards took place in Los Angeles on 14 September…
Political leaders from Scotland, Wales, and Northern Ireland have signed a historic memorandum of understanding…
The retail inflation for India in terms of the Consumer Price Index (CPI) rose to…
Samvatsari Parva 2026 will take place on 15 September 2026, on a Tuesday. This will…
The National Engineers' Day 2026 will be commemorated throughout India on 15 September, which is…